The biotechnology pharmaceutical company Hipra officially opened its new campus in Aiguaviva (Gironès) this Thursday, which aims to become one of the main hubs in animal and human health research and development in Europe. The complex has an investment of €500 million and occupies a total area of 114,000 m2, of which only 28,000 m2 have been occupied so far, the first phase. The institutional event was attended by the Minister of Industry, Jordi Hereu, and the President of the Generalitat (Catalan Government), Salvador Illa.